{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:21:49Z","timestamp":1707178909283},"posted":{"date-parts":[[2023,6,16]]},"group-title":"In Review","reference-count":75,"publisher":"Research Square Platform LLC","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,5,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n        <jats:p>Therapies to revascularize ischemic tissue have long been a goal for the treatment of vascular disease and other disorders. Therapies using stem cell factor (SCF), also known as a c-Kit ligand, had great promise for treating ischemia for myocardial infarct and stroke, however clinical development for SCF was stopped due to toxic side effects including mast cell activation in patients. We recently developed a novel therapy using a transmembrane form of SCF (tmSCF) delivered in lipid nanodiscs. In previous studies, we demonstrated tmSCF nanodiscs were able to induce revascularization of ischemia limbs in mice and did not activate mast cells. To advance this therapeutic towards clinical application, we tested this therapy in an advanced model of hindlimb ischemia in rabbits with hyperlipidemia and diabetes. This model has therapeutic resistance to angiogenic therapies and maintains long term deficits in recovery from ischemic injury. We treated rabbits with local treatment with tmSCF nanodiscs or control solution delivered locally from an alginate gel delivered into the ischemic limb of the rabbits. After eight weeks, we found significantly higher vascularity in the tmSCF nanodisc-treated group in comparison to alginate treated control as quantified through angiography. Histological analysis also showed a significantly higher number of small and large blood vessels in the ischemic muscles of the tmSCF nanodisc treated group. Importantly, we did not observe inflammation or mast cell activation in the rabbits. Overall, this study supports the therapeutic potential of tmSCF nanodiscs for treating peripheral ischemia.<\/jats:p>","DOI":"10.21203\/rs.3.rs-2997323\/v1","type":"posted-content","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T18:25:08Z","timestamp":1686939908000},"source":"Crossref","is-referenced-by-count":1,"title":["Transmembrane Stem Factor Nanodiscs Enhanced Revascularization in a Hind Limb Ischemia Model in Diabetic, Hyperlipidemic Rabbits"],"prefix":"10.21203","author":[{"given":"Eri","family":"Takematsu","sequence":"first","affiliation":[{"name":"The University of Texas at Austin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miles","family":"Massidda","sequence":"additional","affiliation":[{"name":"The University of Texas at Austin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gretchen","family":"Howe","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Goldman","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Felli","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Mei","sequence":"additional","affiliation":[{"name":"The University of Texas at Austin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Callahan","sequence":"additional","affiliation":[{"name":"The University of Texas at Austin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Sligar","sequence":"additional","affiliation":[{"name":"The University of Texas at Austin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Smalling","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Baker","sequence":"additional","affiliation":[{"name":"The University of Texas at Austin"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8761","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.7150\/ijbs.6087","article-title":"The C-Kit Receptor-Mediated Signal Transduction and Tumor-Related Diseases","volume":"9","author":"Liang J","year":"2013","unstructured":"Liang J, Wu Y-L, Chen B-J, Zhang W, Tanaka Y, Sugiyama H. The C-Kit Receptor-Mediated Signal Transduction and Tumor-Related Diseases. International Journal of Biological Sciences. 2013;9:435\u2013443. doi: 10.7150\/ijbs.6087","journal-title":"International Journal of Biological Sciences"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.molmed.2013.12.004","article-title":"Treating the whole not the hole: necessary coupling of technologies for diabetic foot ulcer treatment","volume":"20","author":"Futrega K","year":"2014","unstructured":"Futrega K, King M, Lott WB, Doran MR. Treating the whole not the hole: necessary coupling of technologies for diabetic foot ulcer treatment. Trends in Molecular Medicine. 2014;20:137\u2013142. doi: 10.1016\/j.molmed.2013.12.004","journal-title":"Trends in Molecular Medicine"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.7150\/ijbs.7502","article-title":"The vascular endothelium and human diseases","volume":"9","author":"Rajendran P","year":"2013","unstructured":"Rajendran P, Rengarajan T, Thangavel J, Nishigaki Y, Sakthisekaran D, Sethi G, Nishigaki I. The vascular endothelium and human diseases. International journal of biological sciences. 2013;9:1057\u20131069. doi: 10.7150\/ijbs.7502","journal-title":"International journal of biological sciences"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-s239%J","author":"Avogaro A","year":"2011","unstructured":"Avogaro A, Albiero M, Menegazzo L, de Kreutzenberg S, Fadini GP. Endothelial Dysfunction in Diabetes. The role of reparatory mechanisms. 2011;34:S285-S290. doi: 10.2337\/dc11-s239%J Diabetes Care"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"961","DOI":"10.4239\/wjd.v6.i7.961","article-title":"Peripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomes","volume":"6","author":"Thiruvoipati T","year":"2015","unstructured":"Thiruvoipati T, Kielhorn CE, Armstrong EJ. Peripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomes. World journal of diabetes. 2015;6:961\u2013969. doi: 10.4239\/wjd.v6.i7.961","journal-title":"World journal of diabetes"},{"key":"ref6","first-page":"12","article-title":"Essential Keys To Diagnosing And Treating PAD In Patients With Diabetes","volume":"30","author":"Frank J","year":"2017","unstructured":"Frank J. Tursi CW, and Mary Yost. Essential Keys To Diagnosing And Treating PAD In Patients With Diabetes. Podiatry Today. 2017;30:12\u201317.","journal-title":"Podiatry Today"},{"key":"ref7","author":"Chang R","year":"2011","unstructured":"Chang R. Na M, Steven Wang M, Robert S. Kirsner M, PhD, and Daniel G. Federman M. The Elderly and Peripheral Arterial Disease. In: Consultant 360; Volume\u00a019 - Number 7 - July 2011."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nrd1226","article-title":"Therapeutic angiogenesis in cardiovascular disease","volume":"2","author":"Simons M","year":"2003","unstructured":"Simons M, Ware JA. Therapeutic angiogenesis in cardiovascular disease. Nat Rev Drug Discov. 2003;2:863\u2013871. doi: 10.1038\/nrd1226","journal-title":"Nat Rev Drug Discov"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1161\/ATVBAHA.120.312862","article-title":"Vascular Regeneration in Peripheral Artery Disease","volume":"40","author":"Cooke JP","year":"2020","unstructured":"Cooke JP, Meng S. Vascular Regeneration in Peripheral Artery Disease. Arterioscler Thromb Vasc Biol. 2020;40:1627\u20131634. doi: 10.1161\/ATVBAHA.120.312862","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrcardio.2013.70","article-title":"Therapeutic angiogenesis for critical limb ischaemia","volume":"10","author":"Annex BH","year":"2013","unstructured":"Annex BH. Therapeutic angiogenesis for critical limb ischaemia. Nat Rev Cardiol. 2013;10:387\u2013396. doi: 10.1038\/nrcardio.2013.70","journal-title":"Nat Rev Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.V90.4.1345","article-title":"Stem Cell Factor and Hematopoiesis","volume":"90","author":"Broudy VC","year":"1997","unstructured":"Broudy VC. Stem Cell Factor and Hematopoiesis. Blood. 1997;90:1345\u20131364. doi: 10.1182\/blood.V90.4.1345","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1152\/physrev.00046.2011","article-title":"Stem cell factor receptor\/c-Kit: from basic science to clinical implications","volume":"92","author":"Lennartsson J","year":"2012","unstructured":"Lennartsson J, Ronnstrand L. Stem cell factor receptor\/c-Kit: from basic science to clinical implications. Physiol Rev. 2012;92:1619\u20131649. doi: 10.1152\/physrev.00046.2011","journal-title":"Physiol Rev"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nature10783","article-title":"Endothelial and perivascular cells maintain haematopoietic stem cells","volume":"481","author":"Ding L","year":"2012","unstructured":"Ding L, Saunders TL, Enikolopov G, Morrison SJ. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature. 2012;481:457\u2013462. doi: 10.1038\/nature10783","journal-title":"Nature"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1182\/blood.V84.2.408.408","article-title":"Stem cell factor enhances the survival but not the self-renewal of murine hematopoietic long-term repopulating cells","volume":"84","author":"Li CL","year":"1994","unstructured":"Li CL, Johnson GR. Stem cell factor enhances the survival but not the self-renewal of murine hematopoietic long-term repopulating cells. Blood. 1994;84:408\u2013414.","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/stem.160112","article-title":"Stem cell factor improves the repopulating ability of primitive hematopoietic stem cells after sublethal irradiation (and, to a lesser extent) after bone marrow transplantation in mice","volume":"16","author":"Gardner RV","year":"1998","unstructured":"Gardner RV, Oliver P, Astle CM. Stem cell factor improves the repopulating ability of primitive hematopoietic stem cells after sublethal irradiation (and, to a lesser extent) after bone marrow transplantation in mice. Stem Cells. 1998;16:112\u2013119. doi: 10.1002\/stem.160112","journal-title":"Stem Cells"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"9464","DOI":"10.1073\/pnas.89.20.9464","article-title":"Radioprotection of mice by recombinant rat stem cell factor","volume":"89","author":"Zsebo KM","year":"1992","unstructured":"Zsebo KM, Smith KA, Hartley CA, Greenblatt M, Cooke K, Rich W, McNiece IK. Radioprotection of mice by recombinant rat stem cell factor. Proc Natl Acad Sci U S A. 1992;89:9464\u20139468. doi: 10.1073\/pnas.89.20.9464","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1574889811308010002","article-title":"The role of stem cell factor and granulocyte-colony stimulating factor in treatment of stroke","volume":"8","author":"Zhao LR","year":"2013","unstructured":"Zhao LR, Piao CS, Murikinati SR, Gonzalez-Toledo ME. The role of stem cell factor and granulocyte-colony stimulating factor in treatment of stroke. Recent Pat CNS Drug Discov. 2013;8:2\u201312. doi: 10.2174\/1574889811308010002","journal-title":"Recent Pat CNS Drug Discov"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"104561","DOI":"10.1016\/j.nbd.2019.104561","article-title":"Stem cell factor and granulocyte colony-stimulating factor promote brain repair and improve cognitive function through VEGF-A in a mouse model of CADASIL","volume":"132","author":"Ping S","year":"2019","unstructured":"Ping S, Qiu X, Kyle M, Hughes K, Longo J, Zhao L-R. Stem cell factor and granulocyte colony-stimulating factor promote brain repair and improve cognitive function through VEGF-A in a mouse model of CADASIL. Neurobiology of Disease. 2019;132:104561. doi: https:\/\/doi.org\/10.1016\/j.nbd.2019.104561","journal-title":"Neurobiology of Disease"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005207.pub4","article-title":"Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke","author":"Bath PMW","year":"2013","unstructured":"Bath PMW, Sprigg N, England T. Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke. Cochrane Database of Systematic Reviews. 2013. doi: 10.1002\/14651858.CD005207.pub4","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1161\/CIRCRESAHA.111.263830","article-title":"Stem cell factor gene transfer promotes cardiac repair after myocardial infarction via in situ recruitment and expansion of c-kit + cells","volume":"111","author":"Yaniz-Galende E","year":"2012","unstructured":"Yaniz-Galende E, Chen J, Chemaly E, Liang L, Hulot JS, McCollum L, Arias T, Fuster V, Zsebo KM, Hajjar RJ. Stem cell factor gene transfer promotes cardiac repair after myocardial infarction via in situ recruitment and expansion of c-kit + cells. Circ Res. 2012;111:1434\u20131445. doi: 10.1161\/CIRCRESAHA.111.263830","journal-title":"Circ Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1172\/JCI116164","article-title":"Reversible expansion of primate mast cell populations in vivo by stem cell factor","volume":"91","author":"Galli SJ","year":"1993","unstructured":"Galli SJ, Iemura A, Garlick DS, Gamba-Vitalo C, Zsebo KM, Andrews RG. Reversible expansion of primate mast cell populations in vivo by stem cell factor. J Clin Invest. 1993;91:148\u2013152. doi: 10.1172\/JCI116164","journal-title":"J Clin Invest"},{"key":"ref22","first-page":"427","article-title":"Stem-cell factor, the kit ligand, induces direct degranulation of rat peritoneal mast cells in vitro and in vivo: dependence of the in vitro effect on period of culture and comparisons of stem-cell factor with other mast cell-activating agents","volume":"86","author":"Taylor AM","year":"1995","unstructured":"Taylor AM, Galli SJ, Coleman JW. Stem-cell factor, the kit ligand, induces direct degranulation of rat peritoneal mast cells in vitro and in vivo: dependence of the in vitro effect on period of culture and comparisons of stem-cell factor with other mast cell-activating agents. Immunology. 1995;86:427\u2013433.","journal-title":"Immunology"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1084\/jem.183.6.2681","article-title":"Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo","volume":"183","author":"Costa JJ","year":"1996","unstructured":"Costa JJ, Demetri GD, Harrist TJ, Dvorak AM, Hayes DF, Merica EA, Menchaca DM, Gringeri AJ, Schwartz LB, Galli SJ. Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med. 1996;183:2681\u20132686. doi: 10.1084\/jem.183.6.2681","journal-title":"J Exp Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1472-8206.2005.00390.x","article-title":"Stem cell factor expression, mast cells and inflammation in asthma","volume":"20","author":"Silva CA","year":"2006","unstructured":"Da Silva CA, Reber L, Frossard N. Stem cell factor expression, mast cells and inflammation in asthma. Fundam Clin Pharmacol. 2006;20:21\u201339. doi: 10.1111\/j.1472-8206.2005.00390.x","journal-title":"Fundam Clin Pharmacol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1084\/jem.175.1.245","article-title":"The rat c-kit ligand, stem cell factor, induces c-kit receptor-dependent mouse mast cell activation in vivo. Evidence that signaling through the c-kit receptor can induce expression of cellular function","volume":"175","author":"Wershil BK","year":"1992","unstructured":"Wershil BK, Tsai M, Geissler EN, Zsebo KM, Galli SJ. The rat c-kit ligand, stem cell factor, induces c-kit receptor-dependent mouse mast cell activation in vivo. Evidence that signaling through the c-kit receptor can induce expression of cellular function. J Exp Med. 1992;175:245\u2013255. doi: 10.1084\/jem.175.1.245","journal-title":"J Exp Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1161\/01.cir.98.7.687","article-title":"Stem cell factor induction is associated with mast cell accumulation after canine myocardial ischemia and reperfusion","volume":"98","author":"Frangogiannis NG","year":"1998","unstructured":"Frangogiannis NG, Perrard JL, Mendoza LH, Burns AR, Lindsey ML, Ballantyne CM, Michael LH, Smith CW, Entman ML. Stem cell factor induction is associated with mast cell accumulation after canine myocardial ischemia and reperfusion. Circulation. 1998;98:687\u2013698. doi: 10.1161\/01.cir.98.7.687","journal-title":"Circulation"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1038\/s41467-022-30103-2","article-title":"Transmembrane stem cell factor protein therapeutics enhance revascularization in ischemia without mast cell activation","volume":"13","author":"Takematsu E","year":"2022","unstructured":"Takematsu E, Massidda M, Auster J, Chen PC, Im B, Srinath S, Canga S, Singh A, Majid M, Sherman M, et al. Transmembrane stem cell factor protein therapeutics enhance revascularization in ischemia without mast cell activation. Nat Commun. 2022;13:2497. doi: 10.1038\/s41467-022-30103-2","journal-title":"Nat Commun"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1101\/2022.09.21.508898v1","article-title":"Syndecan-4 Proteoliposomes Enhance Revascularization in a Rabbit Hind Limb Ischemia Model of Peripheral Ischemia","author":"Sligar AD","year":"2022","unstructured":"Sligar AD, Howe G, Goldman J, Felli P, G\u00f3mez-Hern\u00e1ndez A, Takematsu E, Veith A, Shubh D, Riley WJ, Singeetham R, et al. Syndecan-4 Proteoliposomes Enhance Revascularization in a Rabbit Hind Limb Ischemia Model of Peripheral Ischemia. Biorxiv. 2022;https:\/\/www.biorxiv.org\/content\/10.1101\/2022.09.21.508898v1.","journal-title":"Biorxiv"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3791\/58964","article-title":"Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits","author":"Sligar AD","year":"2019","unstructured":"Sligar AD, Howe G, Goldman J, Felli P, Karanam V, Smalling RW, Baker AB. Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits. J Vis Exp. 2019. doi: 10.3791\/58964","journal-title":"J Vis Exp"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e3242","DOI":"10.1002\/dmrr.3242","article-title":"The patient presenting with chronic limb-threatening ischaemia. Does diabetes influence presentation, limb outcomes and survival?","author":"Fitridge R","year":"2019","unstructured":"Fitridge R, Pena G, Mills JL. The patient presenting with chronic limb-threatening ischaemia. Does diabetes influence presentation, limb outcomes and survival? Diabetes Metab Res Rev. 2019:e3242. doi: 10.1002\/dmrr.3242","journal-title":"Diabetes Metab Res Rev"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12933-019-0955-5","article-title":"Diabetes mellitus and other cardiovascular risk factors in lower-extremity peripheral artery disease versus coronary artery disease: an analysis of 1,121,359 cases from the nationwide databases","volume":"18","author":"Takahara M","year":"2019","unstructured":"Takahara M, Iida O, Kohsaka S, Soga Y, Fujihara M, Shinke T, Amano T, Ikari Y, J EVT, investigators JP. Diabetes mellitus and other cardiovascular risk factors in lower-extremity peripheral artery disease versus coronary artery disease: an analysis of 1,121,359 cases from the nationwide databases. Cardiovasc Diabetol. 2019;18:155. doi: 10.1186\/s12933-019-0955-5","journal-title":"Cardiovasc Diabetol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1038\/s41467-022-30103-2","article-title":"Transmembrane stem cell factor protein therapeutics enhance revascularization in ischemia without mast cell activation","volume":"13","author":"Takematsu E","year":"2022","unstructured":"Takematsu E, Massidda M, Auster J, Chen P-C, Im B, Srinath S, Canga S, Singh A, Majid M, Sherman M, et al. Transmembrane stem cell factor protein therapeutics enhance revascularization in ischemia without mast cell activation. Nature Communications. 2022;13:2497. doi: 10.1038\/s41467-022-30103-2","journal-title":"Nature Communications"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1161\/CIRCRESAHA.121.318266","article-title":"New Directions in Therapeutic Angiogenesis and Arteriogenesis in Peripheral Arterial Disease","volume":"128","author":"Annex BH","year":"2021","unstructured":"Annex BH, Cooke JP. New Directions in Therapeutic Angiogenesis and Arteriogenesis in Peripheral Arterial Disease. Circ Res. 2021;128:1944\u20131957. doi: 10.1161\/CIRCRESAHA.121.318266","journal-title":"Circ Res"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.addr.2018.09.010","article-title":"Therapeutic strategies for enhancing angiogenesis in wound healing","volume":"146","author":"Veith AP","year":"2019","unstructured":"Veith AP, Henderson K, Spencer A, Sligar AD, Baker AB. Therapeutic strategies for enhancing angiogenesis in wound healing. Adv Drug Deliv Rev. 2019;146:97\u2013125. doi: 10.1016\/j.addr.2018.09.010","journal-title":"Adv Drug Deliv Rev"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0002-9440(10)65582-4","article-title":"Vascular endothelial growth factor-C (VEGF-C\/VEGF-2) promotes angiogenesis in the setting of tissue ischemia","volume":"153","author":"Witzenbichler B","year":"1998","unstructured":"Witzenbichler B, Asahara T, Murohara T, Silver M, Spyridopoulos I, Magner M, Principe N, Kearney M, Hu JS, Isner JM. Vascular endothelial growth factor-C (VEGF-C\/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am J Pathol. 1998;153:381\u2013394. doi: 10.1016\/S0002-9440(10)65582-4","journal-title":"Am J Pathol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/sj.gt.3301379","article-title":"Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease","volume":"8","author":"Taniyama Y","year":"2001","unstructured":"Taniyama Y, Morishita R, Aoki M, Nakagami H, Yamamoto K, Yamazaki K, Matsumoto K, Nakamura T, Kaneda Y, Ogihara T. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease. Gene Ther. 2001;8:181\u2013189. doi: 10.1038\/sj.gt.3301379","journal-title":"Gene Ther"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1006\/bbrc.1996.1556","article-title":"Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia","volume":"227","author":"Takeshita S","year":"1996","unstructured":"Takeshita S, Weir L, Chen D, Zheng LP, Riessen R, Bauters C, Symes JF, Ferrara N, Isner JM. Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. Biochem Biophys Res Commun. 1996;227:628\u2013635. doi: 10.1006\/bbrc.1996.1556","journal-title":"Biochem Biophys Res Commun"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1161\/01.cir.88.1.208","article-title":"Enhanced revascularization of the ischemic limb by angiogenic therapy","volume":"88","author":"Pu LQ","year":"1993","unstructured":"Pu LQ, Sniderman AD, Brassard R, Lachapelle KJ, Graham AM, Lisbona R, Symes JF. Enhanced revascularization of the ischemic limb by angiogenic therapy. Circulation. 1993;88:208\u2013215. doi: 10.1161\/01.cir.88.1.208","journal-title":"Circulation"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1161\/01.hyp.33.6.1379","article-title":"Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy","volume":"33","author":"Morishita R","year":"1999","unstructured":"Morishita R, Nakamura S, Hayashi S, Taniyama Y, Moriguchi A, Nagano T, Taiji M, Noguchi H, Takeshita S, Matsumoto K, et al. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension. 1999;33:1379\u20131384. doi: 10.1161\/01.hyp.33.6.1379","journal-title":"Hypertension"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.mvr.2010.09.008","article-title":"Mutant hypoxia inducible factor-1alpha improves angiogenesis and tissue perfusion in ischemic rabbit skeletal muscle","volume":"81","author":"Li M","year":"2011","unstructured":"Li M, Liu C, Bin J, Wang Y, Chen J, Xiu J, Pei J, Lai Y, Chen D, Fan C, et al. Mutant hypoxia inducible factor-1alpha improves angiogenesis and tissue perfusion in ischemic rabbit skeletal muscle. Microvasc Res. 2011;81:26\u201333. doi: 10.1016\/j.mvr.2010.09.008","journal-title":"Microvasc Res"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/FJC.0b013e3182982de7","article-title":"NGF promotes hemodynamic recovery in a rabbit hindlimb ischemic model through trkA- and VEGFR2-dependent pathways","volume":"62","author":"Karatzas A","year":"2013","unstructured":"Karatzas A, Katsanos K, Lilis I, Papadaki H, Kitrou P, Lecht S, Marcinkiewicz C, Siablis D, Lelkes PI, Lazarovici P, et al. NGF promotes hemodynamic recovery in a rabbit hindlimb ischemic model through trkA- and VEGFR2-dependent pathways. J Cardiovasc Pharmacol. 2013;62:270\u2013277. doi: 10.1097\/FJC.0b013e3182982de7","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/s0741-5214(98)70269-1","article-title":"Controlled delivery of vascular endothelial growth factor promotes neovascularization and maintains limb function in a rabbit model of ischemia","volume":"27","author":"Hopkins SP","year":"1998","unstructured":"Hopkins SP, Bulgrin JP, Sims RL, Bowman B, Donovan DL, Schmidt SP. Controlled delivery of vascular endothelial growth factor promotes neovascularization and maintains limb function in a rabbit model of ischemia. J Vasc Surg. 1998;27:886\u2013894; discussion 895. doi: 10.1016\/s0741-5214(98)70269-1","journal-title":"J Vasc Surg"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1161\/01.cir.99.23.3043","article-title":"Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo","volume":"99","author":"Fabre JE","year":"1999","unstructured":"Fabre JE, Rivard A, Magner M, Silver M, Isner JM. Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo. Circulation. 1999;99:3043\u20133049. doi: 10.1161\/01.cir.99.23.3043","journal-title":"Circulation"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jconrel.2010.01.010","article-title":"Efficient revascularization by VEGF administration via heparin-functionalized nanoparticle-fibrin complex","volume":"143","author":"Chung YI","year":"2010","unstructured":"Chung YI, Kim SK, Lee YK, Park SJ, Cho KO, Yuk SH, Tae G, Kim YH. Efficient revascularization by VEGF administration via heparin-functionalized nanoparticle-fibrin complex. J Control Release. 2010;143:282\u2013289. doi: 10.1016\/j.jconrel.2010.01.010","journal-title":"J Control Release"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3892\/etm.2012.574","article-title":"Vascular regeneration by pinpoint delivery of growth factors using a microcatheter reservoir system in a rabbit hind-limb ischemia model","volume":"4","author":"Nitta N","year":"2012","unstructured":"Nitta N, Nitta-Seko A, Sonoda A, Watanabe S, Tsuchiya K, Murata K, Tabata Y. Vascular regeneration by pinpoint delivery of growth factors using a microcatheter reservoir system in a rabbit hind-limb ischemia model. Exp Ther Med. 2012;4:201\u2013204. doi: 10.3892\/etm.2012.574","journal-title":"Exp Ther Med"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s00380-006-0934-0","article-title":"Enhanced angiogenesis by gelatin hydrogels incorporating basic fibroblast growth factor in rabbit model of hind limb ischemia","volume":"22","author":"Doi K","year":"2007","unstructured":"Doi K, Ikeda T, Marui A, Kushibiki T, Arai Y, Hirose K, Soga Y, Iwakura A, Ueyama K, Yamahara K, et al. Enhanced angiogenesis by gelatin hydrogels incorporating basic fibroblast growth factor in rabbit model of hind limb ischemia. Heart Vessels. 2007;22:104\u2013108. doi: 10.1007\/s00380-006-0934-0","journal-title":"Heart Vessels"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000139132","article-title":"Vascular effects of FGF-2 and VEGF-B in rabbits with bilateral hind limb ischemia","volume":"46","author":"Wafai R","year":"2009","unstructured":"Wafai R, Tudor EM, Angus JA, Wright CE. Vascular effects of FGF-2 and VEGF-B in rabbits with bilateral hind limb ischemia. J Vasc Res. 2009;46:45\u201354. doi: 10.1159\/000139132","journal-title":"J Vasc Res"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/10623320390246432","article-title":"Therapeutic angiogenesis\/arteriogenesis in the chronic ischemic rabbit hindlimb: effect of venous basic fibroblast growth factor retroinfusion","volume":"10","author":"Lebherz C","year":"2003","unstructured":"Lebherz C, von Degenfeld G, Karl A, Pfosser A, Raake P, Pachmayr F, Scholz D, Kupatt C, Boekstegers P. Therapeutic angiogenesis\/arteriogenesis in the chronic ischemic rabbit hindlimb: effect of venous basic fibroblast growth factor retroinfusion. Endothelium. 2003;10:257\u2013265. doi: 10.1080\/10623320390246432","journal-title":"Endothelium"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"W306-310","DOI":"10.2214\/AJR.07.4013","article-title":"Vascular regeneration by repeated infusions of basic fibroblast growth factor in a rabbit model of hind-limb ischemia","volume":"192","author":"Seko A","year":"2009","unstructured":"Seko A, Nitta N, Sonoda A, Ohta S, Takahashi M, Murata K, Tabata Y. Vascular regeneration by repeated infusions of basic fibroblast growth factor in a rabbit model of hind-limb ischemia. AJR Am J Roentgenol. 2009;192:W306-310. doi: 10.2214\/AJR.07.4013","journal-title":"AJR Am J Roentgenol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.cardiores.2003.10.003","article-title":"Conduction performance of collateral vessels induced by vascular endothelial growth factor or basic fibroblast growth factor","volume":"61","author":"Kondoh K","year":"2004","unstructured":"Kondoh K, Koyama H, Miyata T, Takato T, Hamada H, Shigematsu H. Conduction performance of collateral vessels induced by vascular endothelial growth factor or basic fibroblast growth factor. Cardiovasc Res. 2004;61:132\u2013142. doi: 10.1016\/j.cardiores.2003.10.003","journal-title":"Cardiovasc Res"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1161\/01.CIR.0000147779.17602.18","article-title":"Gelatin hydrogel microspheres enable pinpoint delivery of basic fibroblast growth factor for the development of functional collateral vessels","volume":"110","author":"Hosaka A","year":"2004","unstructured":"Hosaka A, Koyama H, Kushibiki T, Tabata Y, Nishiyama N, Miyata T, Shigematsu H, Takato T, Nagawa H. Gelatin hydrogel microspheres enable pinpoint delivery of basic fibroblast growth factor for the development of functional collateral vessels. Circulation. 2004;110:3322\u20133328. doi: 10.1161\/01.CIR.0000147779.17602.18","journal-title":"Circulation"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.mvr.2009.12.002","article-title":"Synergistic effects of FGF-2 and PDGF-BB on angiogenesis and muscle regeneration in rabbit hindlimb ischemia model","volume":"80","author":"Li J","year":"2010","unstructured":"Li J, Wei Y, Liu K, Yuan C, Tang Y, Quan Q, Chen P, Wang W, Hu H, Yang L. Synergistic effects of FGF-2 and PDGF-BB on angiogenesis and muscle regeneration in rabbit hindlimb ischemia model. Microvasc Res. 2010;80:10\u201317. doi: 10.1016\/j.mvr.2009.12.002","journal-title":"Microvasc Res"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/s0140-6736(02)08937-7","article-title":"Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial","volume":"359","author":"Lederman RJ","year":"2002","unstructured":"Lederman RJ, Mendelsohn FO, Anderson RD, Saucedo JF, Tenaglia AN, Hermiller JB, Hillegass WB, Rocha-Singh K, Moon TE, Whitehouse MJ, et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. Lancet. 2002;359:2053\u20132058. doi: 10.1016\/s0140-6736(02)08937-7","journal-title":"Lancet"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1161\/hc0802.104407","article-title":"Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial","volume":"105","author":"Simons M","year":"2002","unstructured":"Simons M, Annex BH, Laham RJ, Kleiman N, Henry T, Dauerman H, Udelson JE, Gervino EV, Pike M, Whitehouse MJ, et al. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation. 2002;105:788\u2013793. doi: 10.1161\/hc0802.104407","journal-title":"Circulation"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1161\/01.cir.102.5.565","article-title":"Adenovirus-mediated VEGF(121) gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia","volume":"102","author":"Gowdak LH","year":"2000","unstructured":"Gowdak LH, Poliakova L, Wang X, Kovesdi I, Fishbein KW, Zacheo A, Palumbo R, Straino S, Emanueli C, Marrocco-Trischitta M, et al. Adenovirus-mediated VEGF(121) gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia. Circulation. 2000;102:565\u2013571. doi: 10.1161\/01.cir.102.5.565","journal-title":"Circulation"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/nm848","article-title":"Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2","volume":"9","author":"Cao R","year":"2003","unstructured":"Cao R, Brakenhielm E, Pawliuk R, Wariaro D, Post MJ, Wahlberg E, Leboulch P, Cao Y. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med. 2003;9:604\u2013613. doi: 10.1038\/nm848","journal-title":"Nat Med"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1172\/JCI117018","article-title":"Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model","volume":"93","author":"Takeshita S","year":"1994","unstructured":"Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest. 1994;93:662\u2013670. doi: 10.1172\/JCI117018","journal-title":"J Clin Invest"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"596170","DOI":"10.3389\/fcell.2020.596170","article-title":"Cord Lining Mesenchymal Stem Cells Have a Modest Positive Effect on Angiogenesis in Hindlimb Ischemia","volume":"8","author":"Chua K","year":"2020","unstructured":"Chua K, Lim FP, Lee VKM, Phan TT, Tai BC, Tan YK. Cord Lining Mesenchymal Stem Cells Have a Modest Positive Effect on Angiogenesis in Hindlimb Ischemia. Front Cell Dev Biol. 2020;8:596170. doi: 10.3389\/fcell.2020.596170","journal-title":"Front Cell Dev Biol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"e67739","DOI":"10.1371\/journal.pone.0067739","article-title":"Autologous bone-marrow mesenchymal stem cell implantation and endothelial function in a rabbit ischemic limb model","volume":"8","author":"Mikami S","year":"2013","unstructured":"Mikami S, Nakashima A, Nakagawa K, Maruhashi T, Iwamoto Y, Kajikawa M, Matsumoto T, Kihara Y, Chayama K, Noma K, et al. Autologous bone-marrow mesenchymal stem cell implantation and endothelial function in a rabbit ischemic limb model. PLoS One. 2013;8:e67739. doi: 10.1371\/journal.pone.0067739","journal-title":"PLoS One"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1161\/CIRCULATIONAHA.109.856815","article-title":"Priming with angiopoietin-1 augments the vasculogenic potential of the peripheral blood stem cells mobilized with granulocyte colony-stimulating factor through a novel Tie2\/Ets-1 pathway","volume":"120","author":"Kim MS","year":"2009","unstructured":"Kim MS, Lee CS, Hur J, Cho HJ, Jun SI, Kim TY, Lee SW, Suh JW, Park KW, Lee HY, et al. Priming with angiopoietin-1 augments the vasculogenic potential of the peripheral blood stem cells mobilized with granulocyte colony-stimulating factor through a novel Tie2\/Ets-1 pathway. Circulation. 2009;120:2240\u20132250. doi: 10.1161\/CIRCULATIONAHA.109.856815","journal-title":"Circulation"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1745-7254.2005.00168.x","article-title":"Therapeutic neovascularization by autologous transplantation with expanded endothelial progenitor cells from peripheral blood into ischemic hind limbs","volume":"26","author":"Fan CL","year":"2005","unstructured":"Fan CL, Gao PJ, Che ZQ, Liu JJ, Wei J, Zhu DL. Therapeutic neovascularization by autologous transplantation with expanded endothelial progenitor cells from peripheral blood into ischemic hind limbs. Acta Pharmacol Sin. 2005;26:1069\u20131075. doi: 10.1111\/j.1745-7254.2005.00168.x","journal-title":"Acta Pharmacol Sin"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3727\/096368911X623880","article-title":"Pretreatment of endothelial progenitor cells with osteopontin enhances cell therapy for peripheral vascular disease","volume":"21","author":"Vaughan EE","year":"2012","unstructured":"Vaughan EE, Liew A, Mashayekhi K, Dockery P, McDermott J, Kealy B, Flynn A, Duffy A, Coleman C, O'Regan A, et al. Pretreatment of endothelial progenitor cells with osteopontin enhances cell therapy for peripheral vascular disease. Cell Transplant. 2012;21:1095\u20131107. doi: 10.3727\/096368911X623880","journal-title":"Cell Transplant"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1038\/gt.2010.101","article-title":"Naked DNA expressing two isoforms of hepatocyte growth factor induces collateral artery augmentation in a rabbit model of limb ischemia","volume":"17","author":"Pyun WB","year":"2010","unstructured":"Pyun WB, Hahn W, Kim DS, Yoo WS, Lee SD, Won JH, Rho BS, Park ZY, Kim JM, Kim S. Naked DNA expressing two isoforms of hepatocyte growth factor induces collateral artery augmentation in a rabbit model of limb ischemia. Gene Ther. 2010;17:1442\u20131452. doi: 10.1038\/gt.2010.101","journal-title":"Gene Ther"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1161\/01.CIR.0000109700.81266.32","article-title":"Adrenomedullin gene transfer induces therapeutic angiogenesis in a rabbit model of chronic hind limb ischemia: benefits of a novel nonviral vector, gelatin","volume":"109","author":"Tokunaga N","year":"2004","unstructured":"Tokunaga N, Nagaya N, Shirai M, Tanaka E, Ishibashi-Ueda H, Harada-Shiba M, Kanda M, Ito T, Shimizu W, Tabata Y, et al. Adrenomedullin gene transfer induces therapeutic angiogenesis in a rabbit model of chronic hind limb ischemia: benefits of a novel nonviral vector, gelatin. Circulation. 2004;109:526\u2013531. doi: 10.1161\/01.CIR.0000109700.81266.32","journal-title":"Circulation"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1161\/01.cir.102.18.2255","article-title":"Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha\/VP16 hybrid transcription factor","volume":"102","author":"Vincent KA","year":"2000","unstructured":"Vincent KA, Shyu KG, Luo Y, Magner M, Tio RA, Jiang C, Goldberg MA, Akita GY, Gregory RJ, Isner JM. Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha\/VP16 hybrid transcription factor. Circulation. 2000;102:2255\u20132261. doi: 10.1161\/01.cir.102.18.2255","journal-title":"Circulation"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1161\/01.cir.98.19.2081","article-title":"Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb","volume":"98","author":"Shyu KG","year":"1998","unstructured":"Shyu KG, Manor O, Magner M, Yancopoulos GD, Isner JM. Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. Circulation. 1998;98:2081\u20132087. doi: 10.1161\/01.cir.98.19.2081","journal-title":"Circulation"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1161\/01.ATV.0000223865.64812.26","article-title":"Combination of in vivo angiopoietin-1 gene transfer and autologous bone marrow cell implantation for functional therapeutic angiogenesis","volume":"26","author":"Kobayashi K","year":"2006","unstructured":"Kobayashi K, Kondo T, Inoue N, Aoki M, Mizuno M, Komori K, Yoshida J, Murohara T. Combination of in vivo angiopoietin-1 gene transfer and autologous bone marrow cell implantation for functional therapeutic angiogenesis. Arterioscler Thromb Vasc Biol. 2006;26:1465\u20131472. doi: 10.1161\/01.ATV.0000223865.64812.26","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1089\/hum.2007.178","article-title":"Recombinant adeno-associated virus-based gene transfer of cathelicidin induces therapeutic neovascularization preferentially via potent collateral growth","volume":"20","author":"Pinkenburg O","year":"2009","unstructured":"Pinkenburg O, Pfosser A, Hinkel R, Bottcher M, Dinges C, Lebherz C, Sultana S, Enssle J, El-Aouni C, Buning H, et al. Recombinant adeno-associated virus-based gene transfer of cathelicidin induces therapeutic neovascularization preferentially via potent collateral growth. Hum Gene Ther. 2009;20:159\u2013167. doi: 10.1089\/hum.2007.178","journal-title":"Hum Gene Ther"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1745-7254.2007.00527.x","article-title":"Adeno-associated virus vectors simultaneously encoding VEGF and angiopoietin-1 enhances neovascularization in ischemic rabbit hind-limbs","volume":"28","author":"Chen F","year":"2007","unstructured":"Chen F, Tan Z, Dong CY, Chen X, Guo SF. Adeno-associated virus vectors simultaneously encoding VEGF and angiopoietin-1 enhances neovascularization in ischemic rabbit hind-limbs. Acta Pharmacol Sin. 2007;28:493\u2013502. doi: 10.1111\/j.1745-7254.2007.00527.x","journal-title":"Acta Pharmacol Sin"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/aps.2010.67","article-title":"Angiopoiesis and bone regeneration via co-expression of the hVEGF and hBMP genes from an adeno-associated viral vector in vitro and in vivo","volume":"31","author":"Zhang C","year":"2010","unstructured":"Zhang C, Wang KZ, Qiang H, Tang YL, Li Q, Li M, Dang XQ. Angiopoiesis and bone regeneration via co-expression of the hVEGF and hBMP genes from an adeno-associated viral vector in vitro and in vivo. Acta Pharmacol Sin. 2010;31:821\u2013830. doi: 10.1038\/aps.2010.67","journal-title":"Acta Pharmacol Sin"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1161\/01.CIR.0000145139.53840.49","article-title":"Engineered zinc finger-activating vascular endothelial growth factor transcription factor plasmid DNA induces therapeutic angiogenesis in rabbits with hindlimb ischemia","volume":"110","author":"Dai Q","year":"2004","unstructured":"Dai Q, Huang J, Klitzman B, Dong C, Goldschmidt-Clermont PJ, March KL, Rokovich J, Johnstone B, Rebar EJ, Spratt SK, et al. Engineered zinc finger-activating vascular endothelial growth factor transcription factor plasmid DNA induces therapeutic angiogenesis in rabbits with hindlimb ischemia. Circulation. 2004;110:2467\u20132475. doi: 10.1161\/01.CIR.0000145139.53840.49","journal-title":"Circulation"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jss.2005.01.005","article-title":"Vascular endothelial growth factor gene delivery by magnetic DNA nanospheres ameliorates limb ischemia in rabbits","volume":"126","author":"Jiang H","year":"2005","unstructured":"Jiang H, Zhang T, Sun X. Vascular endothelial growth factor gene delivery by magnetic DNA nanospheres ameliorates limb ischemia in rabbits. J Surg Res. 2005;126:48\u201354. doi: 10.1016\/j.jss.2005.01.005","journal-title":"J Surg Res"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3892\/etm.2014.1485","article-title":"Dual gene transfer of bFGF and PDGF in a single plasmid for the treatment of myocardial infarction","volume":"7","author":"Cui K","year":"2014","unstructured":"Cui K, Zhou X, Luo J, Feng J, Zheng M, Huang D, Jiang J, Chen X, Wei Y, Li J, et al. Dual gene transfer of bFGF and PDGF in a single plasmid for the treatment of myocardial infarction. Exp Ther Med. 2014;7:691\u2013696. doi: 10.3892\/etm.2014.1485","journal-title":"Exp Ther Med"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/sj.gt.3301475","article-title":"Adenovirus-mediated ex vivo gene transfer of basic fibroblast growth factor promotes collateral development in a rabbit model of hind limb ischemia","volume":"8","author":"Ohara N","year":"2001","unstructured":"Ohara N, Koyama H, Miyata T, Hamada H, Miyatake SI, Akimoto M, Shigematsu H. Adenovirus-mediated ex vivo gene transfer of basic fibroblast growth factor promotes collateral development in a rabbit model of hind limb ischemia. Gene Ther. 2001;8:837\u2013845. doi: 10.1038\/sj.gt.3301475","journal-title":"Gene Ther"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jss.2003.12.016","article-title":"In vivo electroporation enhances plasmid-based gene transfer of basic fibroblast growth factor for the treatment of ischemic limb","volume":"120","author":"Nishikage S","year":"2004","unstructured":"Nishikage S, Koyama H, Miyata T, Ishii S, Hamada H, Shigematsu H. In vivo electroporation enhances plasmid-based gene transfer of basic fibroblast growth factor for the treatment of ischemic limb. J Surg Res. 2004;120:37\u201346. doi: 10.1016\/j.jss.2003.12.016","journal-title":"J Surg Res"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2997323\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2997323\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T15:25:25Z","timestamp":1707146725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2997323\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":75,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-2997323\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41598-024-52888-6","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2023,6,16]]},"subtype":"preprint"}}